Five new manufacturer restrictions on wholly-owned pharmacies taking effect in July will be “disastrous” for certain health center pharmacy arrangements, [...] …
Articles by : William Newton, Associate Editor/Senior Writer
Two community health centers urged a federal appeals court to reverse an earlier dismissal of their lawsuit alleging four major [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Inflation Reduction Act (IRA) may reduce 340B margins for certain high-cost drugs and drive more transparency into the program, an influential pharmaceutical supply chain analyst who has been a frequent 340B critic told an audience of stakeholders late last
…
A powerful brand-name drug industry trade organization has asked a federal district judge to block Maryland from enforcing the state’s [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Fourteen years after the Congressional deadline, the long-anticipated revision to the 340B Administrative Dispute Resolution (ADR) process officially took effect [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A U.S. senator introduced a bill to extend 340B eligibility to certain outpatient rural hospitals with emergency services, mirroring a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key argument in AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law has already been rejected by a higher [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer Novartis uses contradictory, “whiplash-inducing” arguments in its lawsuit challenging Mississippi’s 340B contract pharmacy law, hospital groups told a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A long-anticipated bipartisan Senate bill to overhaul the 340B program appears on track for introduction before Congress enters recess at [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Delaware House late last week overwhelmingly passed a bill to prohibit drugmaker 340B contract pharmacy restrictions on grantee covered [...] …